Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors
The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome editing system has been the focus of intense research in the last decade due to its superior ability to desirably target and edit DNA sequences. The applicability of the CRISPR-Cas system to in vivo genome editing has acqu...
Main Authors: | Karim Shalaby, Mustapha Aouida, Omar El-Agnaf |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/19/7353 |
Similar Items
-
Viral Vectors for the in Vivo Delivery of CRISPR Components: Advances and Challenges
by: Misganaw Asmamaw Mengstie
Published: (2022-05-01) -
CRISPR/Cas systems: Delivery and application in gene therapy
by: Jie Huang, et al.
Published: (2022-11-01) -
Applications and Research Advances in the Delivery of CRISPR/Cas9 Systems for the Treatment of Inherited Diseases
by: Xinyue Lu, et al.
Published: (2023-08-01) -
Editorial: Current approaches to CRISPR/Cas9 delivery
by: Hasan Uludağ, et al.
Published: (2022-12-01) -
Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma
by: Huimin Kong, et al.
Published: (2021-12-01)